Latest Breaking News On - Venture opportunities fund - Page 2 : comparemela.com

Delcath Systems (DCTH) Announces Additional $35M Funding Tied to the FDA Approval of HEPZATO KIT

Delcath Systems (DCTH) Announces Additional $35M Funding Tied to the FDA Approval of HEPZATO KIT
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Gerard michelDrug administrationDelcath systems incVenture opportunities fundAccess programDelcath systemsPublic equityHepatic delivery systemAvenue venture opportunities fundChief executiveExpanded access program

Delcath Systems, Inc Announces Additional $35 Million in Funding Tied to the FDA Approval of HEPZATO KIT™

NEW YORK, Sept. 1, 2023 /PRNewswire/ Delcath Systems, Inc. , an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today that it.

United statesUnited kingdomBen shamsianGerard michelExchange commissionPrnewswire delcath systems incAccess programVenture opportunities fundDelcath systems incDrug administrationPublic equityHepatic delivery systemAvenue venture opportunities fundChief executiveExpanded access programPercutaneous hepatic perfusion

Aytu BioPharma, Inc : Aytu BioPharma Announces Closing of $4 0 Million Public Offering Priced At-the-Market

Aytu BioPharma, Inc : Aytu BioPharma Announces Closing of $4 0 Million Public Offering Priced At-the-Market
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesRoger weissMark okiAytu biopharmaAbhinav jainAbhinav abi jainNantahala capital managementVenture opportunities fundMaxim groupCompany board of directorsExchange commissionAytu biopharma incAytu biopharma inc viewCompany board of directors upon closingDirectors upon

Aytu BioPharma Announces Closing of $4 0 Million Public Offering Priced At-the-Market

Aytu BioPharma Announces Closing of $4 0 Million Public Offering Priced At-the-Market
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesRoger weissAytu biopharmaAbhinav jainMark okiAbhinav abi jainAytu biopharma incNantahala capital managementVenture opportunities fundMaxim groupCompany board of directors upon closingCompany board of directorsExchange commissionDirectors uponCommon warrants

Aytu BioPharma Announces Closing of $4 0 Million Public Offering Priced

Aytu BioPharma Announces Closing of $4 0 Million Public Offering Priced
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesAbhinav jainAytu biopharmaAbhinav abi jainAytu biopharma incCompany board of directorsCompany board of directors upon closingVenture opportunities fundExchange commissionNantahala capital managementNews networkMaxim groupBiopharma announces closingPublic offering pricedDirectors upon closing